Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-03-11

Clinical Trial Update: A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for LY4057996 in healthy participants and individuals with Type 1 or Type 2 diabetes; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LY4057996

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 1 | Status: RECRUITING